Director’s Council of Public Representatives (COPR)
NIH Public Bulletin – February 2010
NIH and DC Department of Health Team Up to Combat District’s HIV/AIDS Epidemic
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Washington, DC, has one of the highest rates of HIV/AIDS in the country. Approximately 3 percent of adults and children are infected with the virus. Officials from the city and NIH have formed the D.C. Partnership for HIV/AIDS Progress to help answer critical HIV research questions and decrease the rate of new HIV infections in the city.
NIH has allocated $26 million for the first two years of the partnership and will focus on four research areas: developing effective interventions for high-risk populations, establishing a data analysis mechanism to address health issues and outcomes for people receiving HIV treatment, augmenting the city's HIV-related medical care and enhancing access to research studies, and conducting a pilot program to study the voluntary test-and-treat model aimed at reducing the number of new cases of HIV infection. The test-and-treat model suggests that the HIV epidemic can be significantly curtailed through annual, voluntary HIV testing and immediate antiretroviral treatment for individuals who test positive. This research should serve as a model for programs in other U.S. cities.
The partnership is co-led by NIAID and the Washington, DC, Department of Health.
You can learn more about the D.C. Partnership for HIV/AIDS Progress at www.niaid.nih.gov/news/newsreleases/2010/pages/dchivpartnership.aspx.